Status:
COMPLETED
BMT4me: Post-HSCT Medication Adherence mHealth App
Lead Sponsor:
Micah Skeens
Collaborating Sponsors:
National Institute of Nursing Research (NINR)
Conditions:
Stem Cell Transplant
Adherence, Medication
Eligibility:
All Genders
0-21 years
Phase:
NA
Brief Summary
This is a mixed methods, prospective longitudinal pilot RCT to evaluate the 1) acceptability of a newly developed mHealth app (BMT4me), 2) the feasibility of enrolling and retaining caregivers of chil...
Detailed Description
In the United States, poor adherence accounts for up to 70% of all medication-related hospital admissions, resulting in $100 billion in healthcare costs annually Adherence rates have been reported as ...
Eligibility Criteria
Inclusion Criteria:
- Children of caregivers must be a) 0 to 21 years of age; b) receiving immunosuppression for an allogeneic transplant or anti-infective for an autologous transplant; c) discharged prior to Day 100 or completion of immunosuppression taper, and d) residing with the primary caregiver that enrolls on the study.
- Primary caregivers must be: d) English-speaking; and e) have an iOS or Android capable cellular device.
Exclusion Criteria:
- Adults unable to consent
Key Trial Info
Start Date :
November 29 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 21 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05515497
Start Date
November 29 2022
End Date
January 21 2026
Last Update
March 30 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205